CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank
CytoSorbents Corporation, a leader in critical care immunotherapy specializing in blood purification, received an additional $5 million from the Life Sciences Group of Bridge Bank.
CytoSorbents Corporation (“CytoSorbents” or the “Company”) and its U.S. operating subsidiary, CytoSorbents Medical, Inc. began working with Bridge Bank in June, 2016 when they secured an initial $5 million term loan. On June 30, 2017 the Company expanded its relationship to secure an additional $5 million of funding available under their agreement, totaling it’s borrowings to $10 million. The Company intends to use the loan to provide working capital to fund ongoing operations and support clinical trials.
"With our existing cash on hand, this non-dilutive financing further strengthens our balance sheet at an attractive cost of capital and provides sufficient working capital for the foreseeable future, allowing us to continue to pursue our aggressive growth strategy and clinical trial objectives as we increase product sales worldwide and move closer to operating cash flow breakeven,” stated Kathleen Bloch, CPA, MBA, chief financial officer of CytoSorbents Corporation. “We welcome this continuation and expansion of our important relationship with Bridge Bank, a reputable and premier industry provider with a broad scope of financial services.”
“We’ve been working with CytoSorbents for over a year now and believe they possess a truly innovative technology in the life sciences space which could transform critical care medicine and cardiac surgery and save lives throughout the world,” said Justin McDonie, senior vice president for Bridge Bank. “We are pleased to provide this additional capital to support CytoSorbents’ growth at this important juncture in their evolution.”
ABOUT BRIDGE BANK
Bridge Bank is a division of Western Alliance Bank, Member FDIC, the go-to bank for business in its growing markets. Bridge Bank was founded in 2001 in Silicon Valley to offer a better way to bank for small-market and middle-market businesses across many industries, as well as emerging technology companies and the private equity community. Geared to serving both venture-backed and non-venture-backed companies, Bridge Bank offers a broad scope of financial solutions including growth capital, equipment and working capital credit facilities, sustainable energy project finance, venture debt, treasury management, asset-based lending, SBA and commercial real estate loans, ESOP finance and a full line of international products and services. Based in San Jose, Bridge Bank has eight offices in major markets across the country along with Western Alliance Bank’s robust national platform of specialized financial services. Western Alliance Bank is the primary subsidiary of Phoenix-based Western Alliance Bancorporation. One of the country’s top-performing banking companies, Western Alliance ranks #4 on the Forbes 2017 “Best Banks in America” list.
ABOUT CYTOSORBENTS CORPORATION (NASDAQ: CTSO)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 43 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. CytoSorbents has completed its REFRESH (REduction in FREe Hemoglobin) 1 trial – a multi-center, randomized controlled study that has demonstrated the safety and efficacy of free hemoglobin reduction with intra-operative CytoSorb® use in a heart-lung machine during complex cardiac surgery. In 2017, the company plans to initiate a pivotal REFRESH 2 trial intended to support U.S. FDA approval. CytoSorb® has been used safely in more than 23,000 human treatments to date.
CytoSorbents’ purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding in excess of $19 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company’s websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as “may,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements in this press release represent management’s current judgment and expectations, but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, the risks discussed in our Annual Report on Form 10-K, filed with the SEC on March 3, 2017, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business. We caution you not to place undue reliance upon any such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required under the Federal securities laws.
Recent NewsBridge Bank Opens New Office in Seattle, Hires Tom Reimer as Senior Vice PresidentBridge Bank Extends $17MM Credit Facility to SteelHouseBridge Bank Announces Three Leadership ChangesBridge Bank Extends $19MM Loan Facility to Riaz CapitalBridge Bank and Tree Line Capital Partners Provide Senior Debt Financing to Support the Recapitalization of Goettl Air Conditioning by Baum Capital Partners
Recent InsightsDon't Get Hooked: How to Spot a Phishing EmailThe Biggest Trends in Hotel Franchising - 2017 EditionThe Key to Wire Fraud Prevention: Out-of-Band AuthenticationMobile Banking Helps Businesses On The GoConsider the Business Benefits of Payroll Cards — and Keep Employees Happy
Our technology banking group is pleased to announce their latest client relationship with @humanyze, a company that… twitter.com/i/web/status/1… - 1 week 4 days ago“We would like to #congratulate our client, @geteero , on their recent acquisition by @amazon. @geteero is the comp… twitter.com/i/web/status/1… - 1 week 5 days agoBridge Bank is a proud sponsor of this week’s #WomensPESummit (Mar. 13-15), which will be bringing together over 55… twitter.com/i/web/status/1… - 1 week 6 days agoNOTICE: All Bridge Bank offices will be closed on Monday, February 18 in observance of #PresidentsDay pic.twitter.com/TDy6fglKMF“Our Life Sciences Group is pleased to announce their latest transaction with @VeranMedical. Veran helps doctors in… twitter.com/i/web/status/1… - about 2 months 2 days ago"Faith is taking the first step even when you don't see the whole staircase." ~Martin Luther King Jr. #MLK NOTICE:… twitter.com/i/web/status/1… - about 2 months 7 days agoOur Life Sciences Group will be in San Francisco, during the JP Morgan Healthcare Conference #JPM19, the epicenter… twitter.com/i/web/status/1… - about 2 months 3 weeks ago#HappyNewYear! We wish you peace, joy, and prosperity in 2019. NOTICE: All Bridge Bank offices will be closed on J… twitter.com/i/web/status/1… - about 2 months 3 weeks agoFrom all of us here at Bridge Bank, we wish you a #MerryChristmas! NOTICE: All Bridge Bank offices will close at 3… twitter.com/i/web/status/1… - about 3 months 5 days agoWe would like to congratulate our client @Vapotherm on their recent IPO announcement. Vapotherm provides noninvasiv… twitter.com/i/web/status/1… - about 3 months 3 weeks agoWe give our thanks to you and your loved ones this #Thanksgiving holiday. NOTICE: All Bridge Bank offices will be… twitter.com/i/web/status/1… - about 4 months 4 days agoHonoring all who have served. We thank you. pic.twitter.com/aEmnInoP9HIn less than two weeks, we’ll be joining the more than 900 tech enthusiasts, entrepreneurs, premiere investors and… twitter.com/i/web/status/1… - about 5 months 3 weeks ago@HiddenGeniusPro we were very excited to be a part of this celebration. Thank you for the opportunity! twitter.com/HiddenGeniusPr… - about 5 months 3 weeks agoIt’s time for the puck drop! Wishing the @SanJoseSharks another terrific season in tonight’s home opener. Let’s go #Sharks!"Our business customers are looking to grow. And Western Alliance is right there with them with increased capital a… twitter.com/i/web/status/1… - about 5 months 3 weeks agoOur Capital Finance Group is excited to share that our client, Targeted Lease Capital, LLC., experts in equipment f… twitter.com/i/web/status/1… - about 6 months ago"The way we structure our credits is a point of pride in how we do business. It's part of why our customers see us… twitter.com/i/web/status/1… - about 6 months 1 day agoWe understand that no two businesses are exactly alike. That's why Western Alliance bankers tap a sophisticated sui… twitter.com/i/web/status/1… - about 6 months 6 days agoAll of us at Bridge Bank wish the @SanJoseSharks a great preseason game tonight against the Anaheim Ducks!Your friends at Bridge Bank wish everyone a safe and wonderful #LaborDay! REMINDER: In observance of the holiday,… twitter.com/i/web/status/1… - about 6 months 3 weeks agoOur #LifeSciences team is delighted to share its most recent transaction with @OmniGuide, a manufacturer of advance… twitter.com/i/web/status/1… - about 6 months 4 weeks agoBridge Bank is a proud sponsor of the @EastBayHaasAlum. Tonight they host their Annual Party welcoming new… twitter.com/i/web/status/1… - about 7 months 4 days ago"We know our clients and this market, and what's motivating this management team to innovate and persevere just add… twitter.com/i/web/status/1… - about 7 months 1 week agoWe are proud to support @Rhythmix1 as a sponsor of their Pour Your heART Out Benefit for the Arts Celebration takin… twitter.com/i/web/status/1… - about 7 months 2 weeks agoMarkets look to remaining monthly data amidst trade disputes. westernalliancebancorporation.com/bridge-bank-ho… - about 7 months 2 weeks agoWe are proud to sponsor the @LosAltosChamber 29th Annual Golf Tournament today. We hope all of the golfers particip… twitter.com/i/web/status/1… - about 7 months 3 weeks agoLifting up our communities is important to the people of Western Alliance. We live this value in many ways, startin… twitter.com/i/web/status/1… - about 7 months 3 weeks agoStarting from scratch in 2006, @RevolutionFoods has grown to now serve two million healthy meals per week in 1,000+… twitter.com/i/web/status/1… - about 7 months 3 weeks ago